Key result
Multidrug regimen with pulsed steroids, ribavirin, and interferon resolves parvovirus-induced hepatitis and polyarthritis.
Why the study?
Parvovirus B19 infection can cause diverse clinical syndromes including hepatitis and polyarthropathy, but rare manifestations like hepatosplenomegaly require further clinical description.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
May support combined antivirals and corticosteroids in severe parvovirus B19 hepatitis-polyarthritis; hypothesis-generating and requires prospective confirmation.
Parvovirus B19 infection can present with myriads of clinical diseases and syndromes; hepatitis and polyarthropathy are a few of these examples. Parvovirus frequently affects children but this condition has also been reported in adults. The present case report discusses a case of a 43-year-old female who presented to the outpatient department (OPD) with complaints of high-grade fever and pain in multiple joints of her body for three days. On examination, stiffness and swelling of the hand, knees, wrist, and ankles were noted. Laboratory investigations showed highly elevated aspartate transaminase (AST), alanine transaminase (ALT), and bilirubin. Electrocardiogram (ECG) and echocardiogram (ECHO) findings were unremarkable. PCR testing showed the presence of parvovirus. Parvovirus B19 infection led to the development of acute hepatitis, which appeared as yellowing of skin (jaundice) and led to hepatosplenomegaly. Parvovirus-induced polyarthropathy was also observed in the patient. The patient was managed with a parenteral course of ceftriaxone, paracetamol, and a normal saline infusion. Anti-viral drugs were also prescribed to the patient including ribavirin and pegylated interferon. This case study will explore how the patient was diagnosed and managed with conventional therapy and anti-viral to relieve parvovirus-induced hepatitis with hepatosplenomegaly and polyarthritis. Acute hepatitis can be caused by viruses and other noninfectious causes, all of which must be cleared out to avoid chronic disease development. When patients present with joint pain and skin rashes, a thorough workup for viral indicators, medication histories, autoimmune and metabolic illnesses, and parvovirus b19 infection is required.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2022) conducted a case report in Parvovirus b19-induced acute hepatitis and polyarthropathy (n=1). Ceftriaxone, methylprednisolone, ribavirin, and pegylated interferon was evaluated on Symptom improvement. Management with a parenteral course of ceftriaxone, pulsed methylprednisolone, ribavirin, and pegylated interferon resulted in a dramatic and favorable improvement in symptoms of parvovirus-induced hepatitis and polyarthritis.
Synapse has enriched 10 related papers. Consider them for comparative context: